Manulife Financial (MFC.TO) Buy, Sell or Hold

Manulife Financial (MFC.TO)

61.50

-0.03 (0.05%)

as of Sep 24, 2026, 8:00:00 pm Market Open.

1632 watching

COMMENT

He stills likes Sun Life better. He's concerned about the emphasis that Manulife has put on Far Eastern growth they anticipate. Manulife has a checkered history of surprising on the down-side, whereas Sun Life is more predictable. Sun Life has good presence in North America.

TOP PICK

The Canadian stock market has massively under-performed the US for the last decade. MFC-T has under-performed the insurance sector and recovered from all of its miss-steps. It is trading at 10 times earnings, with share buy-backs and debt reduction. (Analysts’ price target is $30.80)

BUY ON WEAKNESS

MFC vs. RY MFC shows a nice uptrend, but facing long-term resistance. It's overbought, so enter around $26 during a sell-off. RY's chart is moderately positive with short-term resistance around $110. Not much upside at the current $107. Enter at $102-103.

BUY

Why is this trading at $27 when it should be over $30? MFC is transitioning. Insurance is a very long-tail businesses with products that need a lot of time to pay off (insurance policies). Their wealth management business in Asia is strong. It's been a long haul for MFC, going back to the Great Recession, and have been making slow progress. They are growing their book value. If things continue, they will grow their earnings and generally improve. She's happy to hold it. They're quarterly results are becoming consistent which will drive the stock. Pays a 3.6% yield.

DON'T BUY

Not a quality growth company. MFC is too hard for him to figure out. He'd rather buy a Canadian or American bank like National Bank.

BUY

MFC vs. SLF When he values lifecos, it's on price to book, dividend yield, or price to earnings, rather than price to cash flows. Sun Life trades at a premium. His preferred lifeco is Manulife, because of a discounted valuation plus a better business overall because of its Asian business. Wealth management is also better, and getting a handle on legacy businesses.

TOP PICK

It hit a 52 week high yesterday. There is potential for a resolution for some of their long term holdings. They are growing in Asia, where there are higher margins. It trades at a sizable valuation discount to its peers in the space. Yield 3.63% (Analysts’ price target is $30.33)

BUY

Recent break-out Jan. 23 to mid-April is the lifecos' (and banks') seasonality. The chart is setting up for a break-out as MFC approaches its highs of early-2018. Chart looks very good, and MFC will do pretty well.

TOP PICK

Superb dividend at 3.73%. Earning have steadily been rising and yet the price hasn't budged much in past year. Its rising fair market value is a good sign and it may go higher. (Analysts’ price target is $30.33)

PAST TOP PICK

(A Top Pick Jan 15/19, Up 33%) You never know when is going to have a good year. They had been increasing their dividend on flat performance so the yield going into last year was well over 4%. He thinks the new management team is doing the right things. It is still discounted relative to its peers. We are unlikely to see another year of 33%.

BUY

It is a good company and he thinks it is going higher. They seem to be on a bit of a roll. You could take some profits if you wanted to.

BUY

MFC vs. CM They were late to get US exposure, which hurt them. Also, there's negativity towards CM's mortgage book. TD and RY remain the top Canadian banks, not CM. TD & RY are investing in tech, the future, which is smart. MFC: The lifecos have done well diversifying into asset management and into Asia. But with low interest rates, pricing insurance gets tougher and limits growth. You own lifecos for Asia and wealth management. Not CM, but buy TD and Royal.

BUY

We had a nice little bottom from August. It is at resistance. $26 has been a resistance since early 2018. As long as the stock market goes higher, it will be good for MFC-T. He likes the insurers over the financials. He only like US financials better that Canadian insurance companies. See his Top Picks today. (Analysts’ price target is $30.00)

COMMENT

Canada has four major life insurance companies. Since the financial crisis, Sun Life aas done the best. He does not see much change at Manulife so would prefer Sun Life.

COMMENT

Enter now for the long term? When interest rates are down, they hurt lifecos. But MFC beat their numbers handily last quarter. Asian operations are strong. He's neutral on insurance companies, because rates are so low. However, their valuation is cheap--but also cheap for so long. In 2020, he'll look at the lifecos again. Problem with lifecos is they're like a black box--you don't know what's inside sometimes.

Showing 331 to 345 of 2,286 entries

Most Recent Experts

Brendan Caldwell

Caldwell Securities

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)